We are live on ! Find out more
ICU icon

SeaStar Medical

26 hedge funds and large institutions have $205K invested in SeaStar Medical in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0% more funds holding

Funds holding: 26 → 26 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

18.5% less ownership

Funds ownership: 20.24% → 1.74% (-18%)

78% less capital inflows, than outflows

Capital inflows: $229K | Capital outflows: $1.03M

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ICU Hedge Fund Activity: Q2 2025 in Review

26 of the 7,627 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2025, worth a combined $205K — down 86% from $1.5M a quarter earlier.

Fund positioning in ICU was balanced in Q2 2025: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $105K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.02M sold.

  • 26 institutional investors held SeaStar Medical (ICU) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $205K of SeaStar Medical stock for Q2 2025, down 86% quarter-over-quarter.
  • 2 funds opened new SeaStar Medical positions in Q2 2025 and 2 closed out, a net change of 0 holders.
  • The largest SeaStar Medical buyer in Q2 2025 was UBS Group, an estimated $105K added.
  • The largest SeaStar Medical seller in Q2 2025 was Armistice Capital, an estimated $1.02M sold.

Based on aggregated 13F filings for Q2 2025.